Skip to content

Comparison of pregabalin and fentanyl after endotracheal intubation

Comparison of hemodynamic responses of Pergabaline and fentanyl after endotracheal intubation in lumbar spine surgery : A double-blind clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20111010007752N12
Enrollment
64
Registered
2021-08-22
Start date
2021-08-23
Completion date
Unknown
Last updated
2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute pain. Other acute postprocedural pain

Interventions

Intervention 1: Intervention group: 8 hours before surgery, 75 mg capsules containing pregabalin (Sanamod company) are administered orally. In addition, fentanyl (Caspian company) 1 microgram/kg in 50

Sponsors

Babol University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age 20-65 years old The American Society of Anesthesiologists (ASA) class I&II ( Grade 1: No cardiovascular, respiratory, glandular and Grade 2: Controlled diabetes)

Exclusion criteria

Exclusion criteria: Drug addiction Hypertension and antihypertensive drugs consumers Difficult intubation Bradycardia

Design outcomes

Primary

MeasureTime frame
Blood Pressure. Timepoint: Before prescribing the drug; before laryngoscopy; after intubation, 1, 3, 5,10 minutes after intubation? after surgical incision. Method of measurement: Monitoring of blood pressure, mm Hg.

Secondary

MeasureTime frame
?Heart Rate. Timepoint: Before prescribing the drug; before laryngoscopy; after intubation, 1, 3, 5,10 minutes after intubation? after surgical incision. Method of measurement: Number per minute.;O2 saturation. Timepoint: Before prescribing the drug; before laryngoscopy; after intubation, 1, 3, 5,10 minutes after intubation? after surgical incision. Method of measurement: Pulse oximeter.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParviz Amri

Babol University of Medical Sciences

pamrimaleh@gmail.com+98 11 3233 8301

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026